Corporate Profile

Acutus Medical is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. We are committed to advancing the field of electrophysiology with a unique array of products and technologies which will enable more physicians to treat more patients more efficiently and effectively. Through internal product development, acquisitions and global partnerships, we have established a global sales presence delivering a comprehensive portfolio of highly differentiated electrophysiology products that provide our customers with a complete solution for catheter-based treatment of cardiac arrhythmias. Founded in 2011, Acutus is based in Carlsbad, California.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Relations

Press Releases

17 Sep '20
CARLSBAD, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today reported financial results for its second quarter ended June 30, 2020. Recent Highlights: Reported revenue of $1.1 million in the second quarter of 2020, a 54% increase over the same quarter
03 Sep '20
CARLSBAD, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today announced it will release its financial results for the second quarter of 2020 after market close on Thursday, September 17, 2020. In conjunction with the release, Acutus will host a

Recent Events

More events are coming soon.

SEC Filings

Filing date Description Form

Quarterly report which provides a continuing view of a company's financial position

10-Q

Report of unscheduled material events or corporate event

8-K

Filing by person(s) reporting owned shares of common stock in a public company >5%

SC 13D